Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN® Basal-Bolus Type 1): a phase 3, randomised, open-label, treat to-target non-inferiority trial - Heller, S; Buse, J; Fisher, M (Lancet, 2012)
et al.